TITLE:
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

CONDITION:
HIV Infections

INTERVENTION:
Anti-HIV Immune Serum Globulin (Human)

SUMMARY:

      To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV
      human serum.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  Proof of HIV infection.

          -  Diagnosis of asymptomatic HIV infection or early AIDS related complex (ARC) with no
             zidovudine (AZT) or other anti-HIV therapy. OR a diagnosis of AIDS and = or > 3
             months of AZT therapy.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following conditions or symptoms are excluded:

          -  HIV-induced neurological disease.

          -  IgA negative.

        Concurrent Medication:

        Excluded:

          -  Immunomodulating agents.

          -  Steroids.

          -  Interferons.

        Patients with the following are excluded:

          -  Active substance abuse.

          -  Use of immunomodulating drugs such as steroids or interferons.

          -  HIV-induced neurological disease.

          -  IgA negative.

        Required with a diagnosis of AIDS:

          -  = or > 3 months of zidovudine (AZT) therapy.

        Active substance abuse.
      
